The session will cover the recent updates on how single-cell genomics is unveiling the clonal heterogeneity of myeloid neoplasia and how this information can guide clinical decisions.
Clonal Heterogeneity and Evolution of Myeloid Neoplasia with Single-cell Genomics
Koichi Takahashi, MD, PhD, UT MD Anderson Cancer Center, Houston, TX, USA
Objectives:
- Understand the technology and potential uses of single cell sequencing.
- Understand current findings from single cells sequencing in myeloid neoplasms and their implications for how myeloid neoplasms first arise, how they involve and the potential implications for patient management.
Recording Date: November 17, 2020
Continuing Education Credit Information
CME/CMLE credit: 1.00 hr
Last day to purchase course and CE claim credit: February 16, 2024
Note: Members of AMP can access this at a discount. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
